Camp Lejeune Settlement Payouts as of March 26th 2024
As of March 26, 2024, the Torts Branch has determined that fifty-one (51) cases in litigation meet the Elective Option (“EO”) criteria through documentary verification.
The case breakdown by injury includes:
14 Bladder Cancer, 12 Kidney Cancer, 10 non-Hodgkin’s Lymphoma, 5 Kidney Disease, 4 Parkinson’s Disease, 4 Leukemia and 2 Multiple Myeloma.
Twenty-one (21) offers have been accepted by plaintiffs on 5 cases of Bladder Cancer ($150,000; $150,000; $300,000; $300,00; $450,000),
4 cases of Kidney Disease (End Stage Renal Disease) ($250,000; $250,000; $100,000; $100,000),
5 cases of Kidney Cancer ($300,000; $300,000; $300,00; $300,000; $150,000),
3 cases of non-Hodgkin’s Lymphoma ($150,000; $150,000; $300,000),
1 case of Multiple Myeloma ($250,000),
2 cases of Parkinson’s Disease ($400,000; $100,000) and
1 case of Leukemia ($300,000).
Nine (9) offers were rejected by plaintiffs, including 4 cases of Bladder Cancer, 2 cases of Kidney Cancer, 1 case of Multiple Myeloma, 1 case of Kidney Disease, and 1 case of Parkinson’s Disease.
Fifteen (15) offers have expired, including 5 cases of Kidney Cancer, 4 cases of non-Hodgkin’s Lymphoma, 4 cases of Bladder Cancer and 2 cases of Leukemia. The other six (6) settlement offers are pending.
